位置:首页 > 蛋白库 > LBP_HUMAN
LBP_HUMAN
ID   LBP_HUMAN               Reviewed;         481 AA.
AC   P18428; B2R938; O43438; Q92672; Q9H403; Q9UD66;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 3.
DT   03-AUG-2022, entry version 187.
DE   RecName: Full=Lipopolysaccharide-binding protein;
DE            Short=LBP;
DE   Flags: Precursor;
GN   Name=LBP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 26-40, VARIANT LEU-436,
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=2402637; DOI=10.1126/science.2402637;
RA   Schumann R.R., Leong S.R., Flaggs G.W., Gray P.W., Wright S.D.,
RA   Mathison J.C., Tobias P.S., Ulevitch R.J.;
RT   "Structure and function of lipopolysaccharide binding protein.";
RL   Science 249:1429-1431(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=7517398; DOI=10.1016/s0021-9258(17)32454-7;
RA   Wilde C.G., Seilhamer J.J., McGrogan M., Ashton N., Snable J.L., Lane J.C.,
RA   Leong S.R., Thornton M.B., Miller K.L., Scott R.W.;
RT   "Bactericidal/permeability-increasing protein and lipopolysaccharide (LPS)-
RT   binding protein. LPS binding properties and effects on LPS-mediated cell
RT   activation.";
RL   J. Biol. Chem. 269:17411-17416(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT LEU-436.
RX   PubMed=9240454; DOI=10.1006/bbrc.1997.6970;
RA   Hubacek J.A., Buchler C., Aslanidis C., Schmitz G.;
RT   "The genomic organization of the genes for human lipopolysaccharide binding
RT   protein (LBP) and bactericidal permeability increasing protein (BPI) is
RT   highly conserved.";
RL   Biochem. Biophys. Res. Commun. 236:427-430(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9441745; DOI=10.1006/geno.1997.5030;
RA   Kirschning C.J., Au-Young J., Lamping N., Reuter D., Pfeil D.,
RA   Seilhamer J.J., Schumann R.R.;
RT   "Similar organization of the lipopolysaccharide-binding protein (LBP) and
RT   phospholipid transfer protein (PLTP) genes suggests a common gene family of
RT   lipid-binding proteins.";
RL   Genomics 46:416-425(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT LEU-436.
RC   TISSUE=Liver;
RA   Long J.Y., Liu J.Q., Xue Y.N., Wang H.X.;
RT   "Cloning and sequencing of human lipopolysaccharide-binding protein gene.";
RL   Sheng Wu Hua Xue Yu Sheng Wu Wu Li Jin Zhan 25:469-471(1998).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J., Buck D., Burrill W.D.,
RA   Butler A.P., Carder C., Carter N.P., Chapman J.C., Clamp M., Clark G.,
RA   Clark L.N., Clark S.Y., Clee C.M., Clegg S., Cobley V.E., Collier R.E.,
RA   Connor R.E., Corby N.R., Coulson A., Coville G.J., Deadman R., Dhami P.D.,
RA   Dunn M., Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H., Rice C.M.,
RA   Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S., Skuce C.D.,
RA   Smith M.L., Soderlund C., Steward C.A., Sulston J.E., Swann R.M.,
RA   Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A., Tracey A.,
RA   Tromans A.C., Vaudin M., Wall M., Wallis J.M., Whitehead S.L.,
RA   Whittaker P., Willey D.L., Williams L., Williams S.A., Wilming L.,
RA   Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-41.
RA   Sutton C.L., Smith R.I.F., Centola M.B., Theofan G.;
RT   "Cloning and characterization of the human LBP upstream sequence.";
RL   Submitted (MAY-1995) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   FUNCTION, AND INTERACTION WITH CD14 AND LIPOPOLYSACCHARIDE.
RX   PubMed=1698311; DOI=10.1126/science.1698311;
RA   Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., Mathison J.C.;
RT   "CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding
RT   protein.";
RL   Science 249:1431-1433(1990).
RN   [11]
RP   REVIEW.
RX   PubMed=17481951; DOI=10.1016/j.ijmm.2007.04.001;
RA   Jerala R.;
RT   "Structural biology of the LPS recognition.";
RL   Int. J. Med. Microbiol. 297:353-363(2007).
RN   [12]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-394.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of multiple
RT   enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [13]
RP   FUNCTION.
RX   PubMed=20133493; DOI=10.1093/intimm/dxq005;
RA   Tsukamoto H., Fukudome K., Takao S., Tsuneyoshi N., Kimoto M.;
RT   "Lipopolysaccharide-binding protein-mediated Toll-like receptor 4
RT   dimerization enables rapid signal transduction against lipopolysaccharide
RT   stimulation on membrane-associated CD14-expressing cells.";
RL   Int. Immunol. 22:271-280(2010).
RN   [14]
RP   FUNCTION, 3D-STRUCTURE MODELING, SUBCELLULAR LOCATION, TISSUE SPECIFICITY,
RP   GLYCOSYLATION, VARIANT LEU-333, AND CHARACTERIZATION OF VARIANT LEU-333.
RX   PubMed=24120359; DOI=10.1016/j.immuni.2013.09.005;
RA   Eckert J.K., Kim Y.J., Kim J.I., Guertler K., Oh D.Y., Sur S., Lundvall L.,
RA   Hamann L., van der Ploeg A., Pickkers P., Giamarellos-Bourboulis E.,
RA   Kubarenko A.V., Weber A.N., Kabesch M., Kumpf O., An H.J., Lee J.O.,
RA   Schumann R.R.;
RT   "The crystal structure of lipopolysaccharide binding protein reveals the
RT   location of a frequent mutation that impairs innate immunity.";
RL   Immunity 39:647-660(2013).
CC   -!- FUNCTION: Plays a role in the innate immune response. Binds to the
CC       lipid A moiety of bacterial lipopolysaccharides (LPS), a glycolipid
CC       present in the outer membrane of all Gram-negative bacteria
CC       (PubMed:7517398, PubMed:24120359). Acts as an affinity enhancer for
CC       CD14, facilitating its association with LPS. Promotes the release of
CC       cytokines in response to bacterial lipopolysaccharide (PubMed:7517398,
CC       PubMed:24120359). {ECO:0000269|PubMed:1698311,
CC       ECO:0000269|PubMed:20133493, ECO:0000269|PubMed:24120359,
CC       ECO:0000269|PubMed:7517398, ECO:0000305|PubMed:17481951}.
CC   -!- SUBUNIT: When bound to LPS, interacts (via C-terminus) with soluble and
CC       membrane-bound CD14. {ECO:0000269|PubMed:1698311,
CC       ECO:0000305|PubMed:17481951}.
CC   -!- INTERACTION:
CC       P18428; P23560-2: BDNF; NbExp=3; IntAct=EBI-3927059, EBI-12275524;
CC       P18428; Q13162: PRDX4; NbExp=4; IntAct=EBI-3927059, EBI-2211957;
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:2402637,
CC       ECO:0000269|PubMed:24120359, ECO:0000269|PubMed:7517398}. Cytoplasmic
CC       granule membrane {ECO:0000250|UniProtKB:P17213}. Note=Membrane-
CC       associated in polymorphonuclear Leukocytes (PMN) granules.
CC       {ECO:0000250|UniProtKB:P17213}.
CC   -!- TISSUE SPECIFICITY: Detected in blood serum (at protein level).
CC       {ECO:0000269|PubMed:2402637, ECO:0000269|PubMed:24120359}.
CC   -!- SIMILARITY: Belongs to the BPI/LBP/Plunc superfamily. BPI/LBP family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M35533; AAA59493.1; -; mRNA.
DR   EMBL; X98657; CAA67226.1; -; Genomic_DNA.
DR   EMBL; X98658; CAA67226.1; JOINED; Genomic_DNA.
DR   EMBL; X98659; CAA67226.1; JOINED; Genomic_DNA.
DR   EMBL; X98660; CAA67226.1; JOINED; Genomic_DNA.
DR   EMBL; X98661; CAA67226.1; JOINED; Genomic_DNA.
DR   EMBL; X98662; CAA67226.1; JOINED; Genomic_DNA.
DR   EMBL; X98663; CAA67226.1; JOINED; Genomic_DNA.
DR   EMBL; X98664; CAA67226.1; JOINED; Genomic_DNA.
DR   EMBL; X98665; CAA67226.1; JOINED; Genomic_DNA.
DR   EMBL; X98666; CAA67226.1; JOINED; Genomic_DNA.
DR   EMBL; X98667; CAA67226.1; JOINED; Genomic_DNA.
DR   EMBL; X98668; CAA67226.1; JOINED; Genomic_DNA.
DR   EMBL; AF013512; AAC39547.1; -; Genomic_DNA.
DR   EMBL; AF013500; AAC39547.1; JOINED; Genomic_DNA.
DR   EMBL; AF013501; AAC39547.1; JOINED; Genomic_DNA.
DR   EMBL; AF013502; AAC39547.1; JOINED; Genomic_DNA.
DR   EMBL; AF013503; AAC39547.1; JOINED; Genomic_DNA.
DR   EMBL; AF013504; AAC39547.1; JOINED; Genomic_DNA.
DR   EMBL; AF013505; AAC39547.1; JOINED; Genomic_DNA.
DR   EMBL; AF013506; AAC39547.1; JOINED; Genomic_DNA.
DR   EMBL; AF013507; AAC39547.1; JOINED; Genomic_DNA.
DR   EMBL; AF013508; AAC39547.1; JOINED; Genomic_DNA.
DR   EMBL; AF013509; AAC39547.1; JOINED; Genomic_DNA.
DR   EMBL; AF013510; AAC39547.1; JOINED; Genomic_DNA.
DR   EMBL; AF013511; AAC39547.1; JOINED; Genomic_DNA.
DR   EMBL; AF105067; AAD21962.1; -; mRNA.
DR   EMBL; AK313625; BAG36385.1; -; mRNA.
DR   EMBL; AL080249; CAC10462.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW76034.1; -; Genomic_DNA.
DR   EMBL; L42172; AAA66446.1; -; Genomic_DNA.
DR   CCDS; CCDS13304.1; -.
DR   PIR; A35843; A35843.
DR   PIR; A54136; A54136.
DR   RefSeq; NP_004130.2; NM_004139.4.
DR   AlphaFoldDB; P18428; -.
DR   SMR; P18428; -.
DR   BioGRID; 110121; 17.
DR   DIP; DIP-90N; -.
DR   IntAct; P18428; 15.
DR   STRING; 9606.ENSP00000217407; -.
DR   TCDB; 1.C.40.1.2; the bactericidal permeability increasing protein (bpip) family.
DR   GlyConnect; 1985; 6 N-Linked glycans (1 site).
DR   GlyGen; P18428; 4 sites, 6 N-linked glycans (1 site).
DR   iPTMnet; P18428; -.
DR   PhosphoSitePlus; P18428; -.
DR   BioMuta; LBP; -.
DR   DMDM; 116242615; -.
DR   CPTAC; non-CPTAC-1140; -.
DR   jPOST; P18428; -.
DR   MassIVE; P18428; -.
DR   MaxQB; P18428; -.
DR   PaxDb; P18428; -.
DR   PeptideAtlas; P18428; -.
DR   PRIDE; P18428; -.
DR   ProteomicsDB; 53558; -.
DR   TopDownProteomics; P18428; -.
DR   Antibodypedia; 777; 406 antibodies from 37 providers.
DR   DNASU; 3929; -.
DR   Ensembl; ENST00000217407.3; ENSP00000217407.2; ENSG00000129988.6.
DR   GeneID; 3929; -.
DR   KEGG; hsa:3929; -.
DR   MANE-Select; ENST00000217407.3; ENSP00000217407.2; NM_004139.5; NP_004130.2.
DR   UCSC; uc002xic.3; human.
DR   CTD; 3929; -.
DR   DisGeNET; 3929; -.
DR   GeneCards; LBP; -.
DR   HGNC; HGNC:6517; LBP.
DR   HPA; ENSG00000129988; Tissue enriched (liver).
DR   MIM; 151990; gene.
DR   neXtProt; NX_P18428; -.
DR   OpenTargets; ENSG00000129988; -.
DR   PharmGKB; PA30303; -.
DR   VEuPathDB; HostDB:ENSG00000129988; -.
DR   eggNOG; KOG4160; Eukaryota.
DR   GeneTree; ENSGT01020000230353; -.
DR   HOGENOM; CLU_028970_3_2_1; -.
DR   InParanoid; P18428; -.
DR   OMA; NPYMEID; -.
DR   OrthoDB; 1242894at2759; -.
DR   PhylomeDB; P18428; -.
DR   TreeFam; TF315617; -.
DR   PathwayCommons; P18428; -.
DR   Reactome; R-HSA-166016; Toll Like Receptor 4 (TLR4) Cascade.
DR   Reactome; R-HSA-166020; Transfer of LPS from LBP carrier to CD14.
DR   Reactome; R-HSA-5686938; Regulation of TLR by endogenous ligand.
DR   Reactome; R-HSA-6785807; Interleukin-4 and Interleukin-13 signaling.
DR   SignaLink; P18428; -.
DR   BioGRID-ORCS; 3929; 14 hits in 1081 CRISPR screens.
DR   ChiTaRS; LBP; human.
DR   GeneWiki; Lipopolysaccharide-binding_protein; -.
DR   GenomeRNAi; 3929; -.
DR   Pharos; P18428; Tbio.
DR   PRO; PR:P18428; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   RNAct; P18428; protein.
DR   Bgee; ENSG00000129988; Expressed in right lobe of liver and 105 other tissues.
DR   Genevisible; P18428; HS.
DR   GO; GO:0009986; C:cell surface; IDA:BHF-UCL.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-KW.
DR   GO; GO:0071723; F:lipopeptide binding; IDA:AgBase.
DR   GO; GO:0001530; F:lipopolysaccharide binding; IDA:MGI.
DR   GO; GO:0070891; F:lipoteichoic acid binding; IDA:MGI.
DR   GO; GO:0005102; F:signaling receptor binding; ISS:BHF-UCL.
DR   GO; GO:0006953; P:acute-phase response; IEP:BHF-UCL.
DR   GO; GO:0006968; P:cellular defense response; ISS:BHF-UCL.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; IDA:MGI.
DR   GO; GO:0071223; P:cellular response to lipoteichoic acid; IDA:MGI.
DR   GO; GO:0050829; P:defense response to Gram-negative bacterium; IDA:BHF-UCL.
DR   GO; GO:0050830; P:defense response to Gram-positive bacterium; IDA:BHF-UCL.
DR   GO; GO:0032490; P:detection of molecule of bacterial origin; IDA:BHF-UCL.
DR   GO; GO:0045087; P:innate immune response; ISS:BHF-UCL.
DR   GO; GO:0002232; P:leukocyte chemotaxis involved in inflammatory response; IEA:Ensembl.
DR   GO; GO:0015920; P:lipopolysaccharide transport; IDA:BHF-UCL.
DR   GO; GO:0031663; P:lipopolysaccharide-mediated signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0033036; P:macromolecule localization; IDA:AgBase.
DR   GO; GO:0002281; P:macrophage activation involved in immune response; IMP:UniProtKB.
DR   GO; GO:0032720; P:negative regulation of tumor necrosis factor production; IDA:BHF-UCL.
DR   GO; GO:0030593; P:neutrophil chemotaxis; IEA:Ensembl.
DR   GO; GO:0008228; P:opsonization; ISS:BHF-UCL.
DR   GO; GO:0032722; P:positive regulation of chemokine production; IEA:Ensembl.
DR   GO; GO:0045919; P:positive regulation of cytolysis; IDA:AgBase.
DR   GO; GO:0032755; P:positive regulation of interleukin-6 production; IDA:BHF-UCL.
DR   GO; GO:0032757; P:positive regulation of interleukin-8 production; IDA:BHF-UCL.
DR   GO; GO:0043032; P:positive regulation of macrophage activation; IDA:BHF-UCL.
DR   GO; GO:0090023; P:positive regulation of neutrophil chemotaxis; IEA:Ensembl.
DR   GO; GO:0060265; P:positive regulation of respiratory burst involved in inflammatory response; ISS:BHF-UCL.
DR   GO; GO:0034145; P:positive regulation of toll-like receptor 4 signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0032760; P:positive regulation of tumor necrosis factor production; IDA:BHF-UCL.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IDA:BHF-UCL.
DR   InterPro; IPR017943; Bactericidal_perm-incr_a/b_dom.
DR   InterPro; IPR030675; BPI/LBP.
DR   InterPro; IPR032942; BPI/LBP/Plunc.
DR   InterPro; IPR030180; LBP.
DR   InterPro; IPR001124; Lipid-bd_serum_glycop_C.
DR   InterPro; IPR017954; Lipid-bd_serum_glycop_CS.
DR   InterPro; IPR017942; Lipid-bd_serum_glycop_N.
DR   PANTHER; PTHR10504; PTHR10504; 1.
DR   PANTHER; PTHR10504:SF66; PTHR10504:SF66; 1.
DR   Pfam; PF01273; LBP_BPI_CETP; 1.
DR   Pfam; PF02886; LBP_BPI_CETP_C; 1.
DR   PIRSF; PIRSF002417; Lipid_binding_protein; 1.
DR   SMART; SM00328; BPI1; 1.
DR   SMART; SM00329; BPI2; 1.
DR   SUPFAM; SSF55394; SSF55394; 2.
DR   PROSITE; PS00400; LBP_BPI_CETP; 1.
PE   1: Evidence at protein level;
KW   Antibiotic; Antimicrobial; Direct protein sequencing; Disulfide bond;
KW   Glycoprotein; Immunity; Innate immunity; Lipid transport; Membrane;
KW   Reference proteome; Secreted; Signal; Transport.
FT   SIGNAL          1..25
FT                   /evidence="ECO:0000269|PubMed:2402637"
FT   CHAIN           26..481
FT                   /note="Lipopolysaccharide-binding protein"
FT                   /id="PRO_0000017158"
FT   CARBOHYD        300
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        355
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        386
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        394
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19159218"
FT   DISULFID        159..198
FT                   /evidence="ECO:0000250|UniProtKB:Q61805"
FT   VARIANT         9
FT                   /note="P -> L (in dbSNP:rs2232580)"
FT                   /id="VAR_028243"
FT   VARIANT         111
FT                   /note="R -> Q (in dbSNP:rs2232583)"
FT                   /id="VAR_049737"
FT   VARIANT         125
FT                   /note="L -> I (in dbSNP:rs2232585)"
FT                   /id="VAR_028244"
FT   VARIANT         147
FT                   /note="E -> K (in dbSNP:rs36015492)"
FT                   /id="VAR_049738"
FT   VARIANT         157
FT                   /note="S -> C (in dbSNP:rs2232586)"
FT                   /id="VAR_061293"
FT   VARIANT         166
FT                   /note="V -> M (in dbSNP:rs5744204)"
FT                   /id="VAR_028245"
FT   VARIANT         242
FT                   /note="M -> I (in dbSNP:rs2232601)"
FT                   /id="VAR_028246"
FT   VARIANT         283
FT                   /note="D -> G (in dbSNP:rs2232607)"
FT                   /id="VAR_028247"
FT   VARIANT         294
FT                   /note="H -> R (in dbSNP:rs2232608)"
FT                   /id="VAR_028248"
FT   VARIANT         333
FT                   /note="P -> L (abolishes lipopolysaccharide binding and
FT                   causes increased proteolytic degradation of the protein;
FT                   dbSNP:rs2232613)"
FT                   /evidence="ECO:0000269|PubMed:24120359"
FT                   /id="VAR_028249"
FT   VARIANT         339
FT                   /note="L -> F (in dbSNP:rs5744212)"
FT                   /id="VAR_028250"
FT   VARIANT         364
FT                   /note="I -> T (in dbSNP:rs2232615)"
FT                   /id="VAR_049739"
FT   VARIANT         436
FT                   /note="F -> L (in dbSNP:rs2232618)"
FT                   /evidence="ECO:0000269|PubMed:2402637,
FT                   ECO:0000269|PubMed:9240454, ECO:0000269|Ref.5"
FT                   /id="VAR_028251"
FT   VARIANT         445
FT                   /note="A -> T (in dbSNP:rs2232619)"
FT                   /id="VAR_028252"
FT   CONFLICT        6
FT                   /note="R -> H (in Ref. 2)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        22
FT                   /note="E -> C (in Ref. 2)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        82
FT                   /note="N -> K (in Ref. 4; AAC39547)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        128
FT                   /note="S -> F (in Ref. 4; AAC39547)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        154..157
FT                   /note="VTAS -> GYCL (in Ref. 1; AAA59493)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        174
FT                   /note="L -> S (in Ref. 1; AAA59493)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        257
FT                   /note="R -> S (in Ref. 4; AAC39547)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        266..270
FT                   /note="VMSLP -> A (in Ref. 1; AAA59493)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        369
FT                   /note="L -> H (in Ref. 4; AAC39547)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   481 AA;  53384 MW;  5A0E4B9E5E604C72 CRC64;
     MGALARALPS ILLALLLTST PEALGANPGL VARITDKGLQ YAAQEGLLAL QSELLRITLP
     DFTGDLRIPH VGRGRYEFHS LNIHSCELLH SALRPVPGQG LSLSISDSSI RVQGRWKVRK
     SFFKLQGSFD VSVKGISISV NLLLGSESSG RPTVTASSCS SDIADVEVDM SGDLGWLLNL
     FHNQIESKFQ KVLESRICEM IQKSVSSDLQ PYLQTLPVTT EIDSFADIDY SLVEAPRATA
     QMLEVMFKGE IFHRNHRSPV TLLAAVMSLP EEHNKMVYFA ISDYVFNTAS LVYHEEGYLN
     FSITDDMIPP DSNIRLTTKS FRPFVPRLAR LYPNMNLELQ GSVPSAPLLN FSPGNLSVDP
     YMEIDAFVLL PSSSKEPVFR LSVATNVSAT LTFNTSKITG FLKPGKVKVE LKESKVGLFN
     AELLEALLNY YILNTFYPKF NDKLAEGFPL PLLKRVQLYD LGLQIHKDFL FLGANVQYMR
     V
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024